Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Liver Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB, WITH OR WITHOUT TIRAGOLUMAB, IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (CO44668)

  • Details

ClinicalTrials.gov ID: NCT05904886
Diagnosis Type: Liver Cancer
USOR Number: 23261

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, MN 55125
P: (651) 735-7414

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB, WITH OR WITHOUT TIRAGOLUMAB, IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (CO44668)

  • Details

ClinicalTrials.gov ID: NCT05904886
Diagnosis Type: Liver Cancer
USOR Number: 23261

  • Practice Details

1580 Beam Avenue
Maplewood, MN 55109
P: (651) 779-7978

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB, WITH OR WITHOUT TIRAGOLUMAB, IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (CO44668)

  • Details

ClinicalTrials.gov ID: NCT05904886
Diagnosis Type: Liver Cancer
USOR Number: 23261

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, MN 55404
P: (612) 884-6300

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Edina

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB, WITH OR WITHOUT TIRAGOLUMAB, IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (CO44668)

  • Details

ClinicalTrials.gov ID: NCT05904886
Diagnosis Type: Liver Cancer
USOR Number: 23261

  • Practice Details

6545 France Avenue, Suite 210
Edina, MN 55435
P: (952) 928-2900

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Fridley

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB, WITH OR WITHOUT TIRAGOLUMAB, IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (CO44668)

  • Details

ClinicalTrials.gov ID: NCT05904886
Diagnosis Type: Liver Cancer
USOR Number: 23261

  • Practice Details

480 Osborne Rd NE, Suite 220
Fridley, MN 55432
P: (763) 786-1620

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Burnsville

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB, WITH OR WITHOUT TIRAGOLUMAB, IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (CO44668)

  • Details

ClinicalTrials.gov ID: NCT05904886
Diagnosis Type: Liver Cancer
USOR Number: 23261

  • Practice Details

675 E Nicollet Blvd, Suite 100
Burnsville, MN 55337
P: (952) 892-7190

More Details View Practice Page

Liver Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB, WITH OR WITHOUT TIRAGOLUMAB, IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (CO44668)

  • Details

ClinicalTrials.gov ID: NCT05904886
Diagnosis Type: Liver Cancer
USOR Number: 23261

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A PHASE 2 STUDY OF ALISERTIB IN PATIENTS WITH EXTENSIVE SMALL CELL LUNG CANCER (PUMA-ALI-4201)

  • Details

ClinicalTrials.gov ID: NCT06095505
Diagnosis Type: Lung Cancer
USOR Number: 23243

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, MN 55125
P: (651) 735-7414

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

A PHASE 2 STUDY OF ALISERTIB IN PATIENTS WITH EXTENSIVE SMALL CELL LUNG CANCER (PUMA-ALI-4201)

  • Details

ClinicalTrials.gov ID: NCT06095505
Diagnosis Type: Lung Cancer
USOR Number: 23243

  • Practice Details

1580 Beam Avenue
Maplewood, MN 55109
P: (651) 779-7978

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A PHASE 2 STUDY OF ALISERTIB IN PATIENTS WITH EXTENSIVE SMALL CELL LUNG CANCER (PUMA-ALI-4201)

  • Details

ClinicalTrials.gov ID: NCT06095505
Diagnosis Type: Lung Cancer
USOR Number: 23243

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, MN 55404
P: (612) 884-6300

More Details View Practice Page
1 2 3 21